Jun 03, 2019

Starpharma signs second oncology agreement with AstraZeneca

Starpharma signs second oncology agreement with AstraZeneca

Online investor news outlet Finance News Network reported on Starpharma’s second oncology agreement with global pharmaceutical giant AstraZeneca, noting that this is for the development of a DEP® version of an undisclosed and existing market oncology drug.

Read the full article here (requires sign in).

 This contains certain forward-looking statements.